Background Hepatitis D is the most severe form of chronic viral hepatitis. Treatment guidelines
recommend 1 year of peginterferon alfa, which is effective in 25–30% of patients only. …

OBJECTIVES: The objectives of this study were to identify the causative microorganisms and
factors associated with survival in patients with Fournier's gangrene and to determine the …

HIV-1 replication is rapid and highly error-prone. Transmission of a drug-resistant HIV-1
strain is possible and occurs within the HIV-1-infected population. In this study, we aimed to …

Objective: To obtain regional epidemiological data on hepatitis delta virus (HDV, a defective
virus) infections, the incidence of anti-HDV positivity and the associated risk factors in …

Background CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown
to be well tolerated with a good safety profile in individuals aged 18 years and older in …

Background & Aims Tenofovir alafenamide (TAF) is a new prodrug of tenofovir developed to
treat patients with chronic hepatitis B virus (HBV) infection at a lower dose than tenofovir …

Objectives: Results from two Phase 3 studies, through 2 years, in chronic hepatitis B infection
(CHB) showed tenofovir alafenamide (TAF) had similar efficacy to tenofovir disoproxil …

AIM: To evaluate the effects of tenofovir disoproxil fumarate (TDF) use during late pregnancy
to reduce hepatitis B virus (HBV) transmission in highly viremic mothers. METHODS: This …

No data on whether brucellar meningitis or meningoencephalitis can be treated with oral
antibiotics or whether an intravenous extended-spectrum cephalosporin, namely, ceftriaxone, …

Background: Chronic hepatitis B (CHB) is a viral infection that can result in life-threatening
conditions, such as hepatocellular carcinoma and cirrhosis. Tenofovir, which is used for the …